Scinai Immunotherapeutics Ltd – ADR SCNI shares are surging Friday morning after the company announced fresh financing tied ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious ...

Scinai Immunotherapeutics Ltd. ADR Annual stock financials by MarketWatch. View the latest SCNI financial statements, income statements and financial ratios.

SCNI is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of SCNI shares has decreased $0.03 since the market last closed. This is a 4.03 ...